Riskpilot← Back to searchSign inGet full accessFDA Retail AB
ABActiveOrg 5560867417Södra Torngatan 17Activities of head offices · NACE 7010Est. 19632 employees
Revenue 2025
SEK 5,4M
-10% vs 2024
EBITDA margin
10.4%
-7% vs 2024
Equity ratio
97.4%
Financial strength
Net profit 2025
SEK 21,1M
-26% vs 2024
| Revenue | SEK 5,4M | -10% |
| EBITDA | SEK 562K | -7% |
| Net profit | SEK 21,1M | -26% |
| Total assets | SEK 415,7M | +3% |
| Equity | SEK 404,8M | +3% |
| Employees | 2 | — |
Legal name
FDA Retail AB
Org number
5560867417
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
5 mars 1963
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Fredriksson, Anders Gunnar Oscar Fredriksson, Doris Margarete
Company purpose
Bolaget skall som medlem i ICA Förbundet bedriva detaljhandels- rörelse med dagligvaror. Dessutom bedriva leasingverksamhet, handel med värdepapper och köp och likvidering av bolag samt annan därmed förenlig verksamhet.
Address
Södra Torngatan 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 17 307 | 28 541 | 24 881 | 28 945 | 58 081 | 5 736 | 5 970 | 5 383 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 10 243 | −1 219 | 942 | −1 626 | 841 | 298 | 440 | 12 501 | 557 | 603 | 562 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | 10 243 | −1 219 | 942 | −1 626 | 841 | 298 | 440 | 12 501 | 557 | 603 | 562 |
| Net financials | 3 457 | 12 368 | 17 058 | 23 105 | 13 197 | 12 698 | 27 182 | −8 430 | 57 369 | 13 872 | 16 301 |
| Profit before tax | 14 845 | 12 262 | 26 000 | 31 742 | 25 465 | 25 228 | 62 008 | 29 199 | 76 915 | 34 185 | 23 050 |
| Tax | −3 247 | −515 | −2 638 | −2 627 | −3 415 | −3 278 | −8 418 | −7 373 | −5 166 | −5 647 | −1 915 |
| Net profit | 11 598 | 11 747 | 23 362 | 29 115 | 22 050 | 21 950 | 53 590 | 21 826 | 71 749 | 28 538 | 21 135 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 206 532 | 204 239 | 217 523 | 239 391 | 252 098 | 264 856 | 314 276 | 324 626 | 386 983 | 405 152 | 415 676 |
| Equity | 196 776 | 201 523 | 214 884 | 233 999 | 246 049 | 258 000 | 301 590 | 313 416 | 375 165 | 393 703 | 404 838 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 284 | 355 | 278 | 295 | 379 | 420 | 5 637 | 4 659 | 6 256 | 598 | 821 |
| Total debt | 6 284 | 355 | 278 | 295 | 379 | 420 | 5 637 | 4 659 | 6 256 | 598 | 821 |
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
20152025
Equity ratio
97.4%
This company
38.2%
Market median
+155% vs market
20152025
Return on equity
5.2%
This company
18.4%
Market median
-72% vs market
20152025
Net profit margin
392.6%
This company
8.1%
Market median
+4747% vs market
20152025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20152025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-09-01 – 2015-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AM Audit | Audit | 2021 | — | — |
EM Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FDA Retail AB 
FDA Future ABBoard members of FDA Retail AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Magnus Nyman | Audit | 0 companies |
| Eva Marina Svensson | Chief Auditor | 0 companies |
| Anders Gunnar Oscar Fredriksson | Chairman | 0 companies |
| Doris Margarete Fredriksson | Board of Directors | 0 companies |
| Eric A O Fredriksson Wistrand | Deputy Board Member | 0 companies |
| Sara Margareta Gyltman | Deputy Board Member | 0 companies |